USFDA concludes inspection at Gland Pharma Visakhapatnam facility with zero 483 observations Ruchika Sharma31 July 2023 11:27 AM ISTTelangana: Gland Pharma has announced that the United States Food and Drug Administration (US FDA) has conducted Good Manufacturing Practice...
Gland Pharma gets one 483 Observation from USFDA for Dundigal facility Ruchika Sharma14 July 2023 1:29 PM ISTHyderabad: Gland Pharma today announced that the United States Food and Drug Administration (USFDA) has issued one 483 Observation...
Gland Pharma gets one USFDA observation for Pashamylaram Facility Ruchika Sharma28 Jun 2023 11:15 AM ISTHyderabad: Gland Pharma has recently announced that the US Food and Drug Administration (USFDA) has concluded the inspection at the...
Gland Pharma reports 56 percent decline in Q4 profit on soft demand Ruchika Sharma19 May 2023 1:30 PM ISTThe company operated in a "challenging business environment (in the year ended March)," Gland Pharma CEO Srinivas Sadu said in a statement.
Fosun Pharma withdraws plans to sell stake in Gland Pharma Ruchika Sharma26 April 2023 11:37 AM ISTBengaluru: China's Shanghai Fosun Pharmaceutical Group Co Ltd has withdrawn plans to sell stake in Indian drugmaker Gland Pharma Ltd, ET Now...
Hetero, Sun Pharma recall products in US over manufacturing issues Ruchika Sharma24 April 2023 12:15 PM ISTHetero USA Inc is recalling 2,352 bottles of Pantoprazole Sodium delayed release tablets for "CGMP Deviations: Discoloration", the USFDA stated.
Gland Pharma to infuse Rs 400 crore to expand Genome Valley facility Ruchika Sharma21 Feb 2023 11:35 AM ISTRama Rao said,"I am delighted that Gland Pharma will be investing Rs 400 crores in expanding their footprint in Hyderabad and will create 500 more...
USFDA issues zero observations for Gland Pharma Visakhapatnam API facility Ruchika Sharma28 Jan 2023 1:00 PM ISTVisakhapatnam: Gland Pharma has recently announced that the company has received zero observations from the US Food and Drug Administration (USFDA)...
Gland Pharma net profit declines 15 percent to Rs 232 crore in Q3 Ruchika Sharma26 Jan 2023 10:00 AM ISTDuring the quarter, total R&D expense stood at Rs 51.2 crore, at 5.5 percent of revenue, the company said, adding the total capex incurred during the...
Gland Pharma to acquire 100 percent stake in Cenexi Group Ruchika Sharma7 Jan 2023 1:00 PM ISTNew Delhi: Drug firm Gland Pharma has inked a pact with FPCI Sino French Midcap Fund to acquire 100 percent stake in Europe-based Cenexi Group.Gland...
Gland Pharma gets UFSDA EIR for Dundigal Facility Ruchika Sharma5 Jan 2023 2:30 PM ISTHyderabad: Gland Pharma has received the Establishment Inspection Report (EIR) from the Office of Product Evaluation and Quality Center for Devices...
Gland Pharma Singapore arm to acquire Cenexi Group for over Rs 1000 crore Ruchika Sharma30 Nov 2022 4:30 PM ISTThe acquisition provides Gland Pharma access to leading know-how and development capabilities in sterile forms including for ophthalmic gel,...
